Search Results

Influenza is a common, highly contagious infection that can lead to life-threatening complications. Learn more about influenza and our cutting-edge vaccines.

https://www.seqirus.com/expertise/influenza

Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.seqirus.com/expertise

Why we can’t overlook influenza in the midst of the ongoing COVID-19 pandemic.

https://www.seqirus.com/vita/2022/influenza-vaccination-our-best-tool-for-safeguarding-communities-from-influenza

New Data Supports the Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Reducing Influenza-Related Hospitalizations and Healthcare Costs in Older Adults

https://www.seqirus.com/news/seqirus-presents-new-data-at-eswi-8th-virtual-conference

The new pre-filled syringe line has received FDA approval and will support influenza vaccine production for the 2022/23 Northern Hemisphere season and beyond.

https://www.seqirus.com/news/seqirus-completes-$156-million-expansion-to-hsp-manufacturing-facility

Renewal reaffirms longstanding, public-private partnership between Seqirus and the Biomedical Advanced Research and Development Authority (BARDA)

https://www.seqirus.com/news/seqirus-and-us-gov-renew-multi-year-agreement-for-influenza-pandemic-preparedness-and-response

Families Fighting Flu’s president, Shelle Allen, shares her daughter’s story and why influenza is more than just a bad cold.

https://www.seqirus.com/vita/2022/the-hidden-impact-of-influenza

New facility in Waltham, Massachusetts, will support CSL’s growing R&D portfolio, including the self-amplifying mRNA technology platform.

https://www.seqirus.com/news/seqirus-announces-new-facility-supporting-research-and-development-of-influenza-vaccine-technology

Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.

https://www.seqirus.com/manufacturing/technologies

Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.

https://www.seqirus.com/expertise/influenza/pandemic-response-solutions